Marjolein van Egmond

PROF.DR., (Principal Investigator)

20082019
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2019

  • 57 Article
  • 9 Research VU University Amsterdam, graduation VU University Amsterdam
  • 5 Review article
  • 3 Meeting Abstract

CD62L Is a Functional and Phenotypic Marker for Circulating Innate Lymphoid Cell Precursors

Bar-Ephraim, Y. E., Koning, J. J., Burniol Ruiz, E., Konijn, T., Mourits, V. P., Lakeman, K. A., Boon, L., Bögels, M., van Maanen, J. P., den Haan, J. M. M., van Egmond, M., Bouma, G., Reijmers, R. M. & Mebius, R. E., 2019, In : Journal of Immunology. 202, 1, p. 171-182

Research output: Contribution to journalArticleAcademicpeer-review

Efficient Innate Immune Killing of Cancer Cells Triggered by Cell-Surface Anchoring of Multivalent Antibody-Recruiting Polymers

Uvyn, A., de Coen, R., Gruijs, M., Tuk, C. W., de Vrieze, J., van Egmond, M. & de Geest, B. G., 2019, In : Angewandte Chemie International Edition in English. 58, 37, p. 12988-12993

Research output: Contribution to journalArticleAcademicpeer-review

FcγRIIIb restricts antibody-dependent destruction of cancer cells by human neutrophils

Treffers, L. W., van Houdt, M., Bruggeman, C. W., Heineke, M. H., Zhao, X. W., van der Heijden, J., Nagelkerke, S. Q., Verkuijlen, P. J. J. H., Geissler, J., Lissenberg-Thunnissen, S., Valerius, T., Peipp, M., Franke, K., van Bruggen, R., Kuijpers, T. W., van Egmond, M., Vidarsson, G., Matlung, H. L. & van den Berg, T. K., 1 Jan 2019, In : Frontiers in Immunology. 10, JAN, 03124.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

IgA and FcαRI: Pathological Roles and Therapeutic Opportunities

Breedveld, A. & van Egmond, M., 2019, In : Frontiers in Immunology. 10, p. 553

Research output: Contribution to journalReview articleAcademicpeer-review

Open Access

Mesangial deposition can strongly involve innate-like iga molecules lacking affinity maturation

Wehbi, B., Oblet, C., Boyer, F., Huard, A., Druilhe, A., Paraf, F., Cogné, E., Moreau, J., Makhour, Y. E., Badran, B., van Egmond, M., Cogné, M. & Aldigier, J-C., 1 Jul 2019, In : Journal of the American Society of Nephrology. 30, 7, p. 1238-1249

Research output: Contribution to journalArticleAcademicpeer-review

Activities 2018 2018

  • 9 Invited talk
  • 4 Membership of committee
  • 1 Organising a conference, workshop, ...
  • 1 Examination

‘Immunoglobulin A; Trojan horse or magic bullet?’

Marjolein van Egmond (Keynote speaker)
21 Apr 2018

Activity: Talk or presentationInvited talk

European Phagocyte Group (External organisation)

M van Egmond (Member)
2018

Activity: MembershipMembership of committee

‘Translating antibody – effector cell cross-talk to immunotherapy’.

Marjolein van Egmond (Invited speaker)
25 Feb 20182 Mar 2018

Activity: Talk or presentationInvited talk

‘Immunoglobulin A: Trojan horse or magic bullet?’

Marjolein van Egmond (Invited speaker)
11 Sep 2018

Activity: Talk or presentationInvited talk

Thesis committee E. Heideveld, Sanquin (External organisation)

Marjolein van Egmond (Chair)
2018

Activity: MembershipMembership of committee

Press / Media

Libelle article: Feiten & Fabels over kanker

Marjolein van Egmond

08/08/2018

1 media contribution

Press/Media: Public Engagement Activities